SAB Biotherapeutics awarded $57.5m from BARDA and US Department of Defense for SAB-185

SAB Biotherapeutics awarded $57.5m from BARDA and US Department of Defense for SAB-185. (Credit: fernando zhiminaicela from Pixabay)